New hope for sickle cell brains: drug boosts blood flow in small trial
NCT ID NCT05725902
First seen Jan 07, 2026 · Last updated May 12, 2026 · Updated 14 times
Summary
This study tested a drug called etavopivat in 12 children and young adults (ages 12–21) with sickle cell disease. The goal was to see if it could improve blood flow and oxygen delivery to the brain and muscles. Participants took the drug for a period, and researchers measured changes in brain blood flow and oxygen use. The study was small and early-stage, so results help guide future research rather than proving a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Children's Healthcare of Atlanta
Atlanta, Georgia, 30342, United States
Conditions
Explore the condition pages connected to this study.